EUVIMEDEUVIMED entdecken
Crossref

NLRP3 neuroinflammatory intervention of Mahuang-Lianqiao-Chixiaodou decoction for mental disorders in atopic dermatitis mice

Huimin Yuan, Yang Tang, Shujing Zhang, Shuxin Yan, Aorou Li, Yanru Yu, Yan Sun, Fengjie Zheng

Journal of Ethnopharmacology · 2024

DOI: 10.1016/j.jep.2023.117263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2024. Verfasst von Huimin Yuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Mental Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Mahuang-Lianqiao-Chixiaodou decoction (MLCD) is a traditional Chinese medicinal (TCM) formula recorded in the Treatise on Febrile Diseases. It is commonly used for clinical treatment of atopic dermatitis (AD). However, the potential mechanisms of MLCD intervention in AD combined with mental disorders behaviors such as anxiety and depression remain elusive and deserves further investigation. AIM OF THE STUDY: The study aims to observe the effect of MLCD on anxiety- and depression-like behaviors in AD mice and explore the possible neuroinflammatory mechanism of NOD-like receptor 3 (NLRP3) inflammasome. MATERIALS AND METHODS: The chemical components of MLCD extracts were identified using UHPLC-MS. The AD mice were induced by 2,4-dinitrofluorobenzene and treated with MLCD or mometasone furoate (MF, as a positive control) for 7 days. The pathological changes in their skin tissue and brain hippocampus were observed by hematoxylin-eosin staining. Elevated plus-maze test (EPM), open field test (OFT), and the suspended tail (TST) were used to measure the anxiety- and depressive-like behaviors in AD mice. Expression of NLRP3 inflammasome-related proteins in brain hippocampus were measured by the quantitative real-time polymerase chain reaction (qPCR) and western blotting (WB). RESULTS: We found that MLCD contain many active ingredients, including ephedrine, Forsythoside A, phillyrin, glycyrrhizic acid, etc. Both MLCD and MF alleviated skin lesions and promoted positive histopathological changes in the hippocampus of AD mince to varying degrees. MLCD however, could further increase their proportion of open arm entry times (Oentries%) in EPM, residence time in the central area (Ctime) and the proportion of the number of times in the central area (Centries%) in OFT significantly. MLCD also reduces their immobility time in TST considerably. Mechanistically, MLCD downregulated the relative mRNA expression and protein level of NLRP3, Caspase-1, IL-1β, and IL-18 in hippocampal tissue compared to the model group. CONCLUSIONS: MLCD can alleviate anxiety-like and depression-like behaviors in AD mice by intervening in the gene and protein expression of NLRP3 inflammasome-related factors, thus treating AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicMental DisordersHumansMiceAnimalsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNLR ProteinsDrugs, Chinese Herbal

Stichwörter der Autor:innen

Atopic dermatitisMahuang-Lianqiao-Chixiaodou decoctionMental disordersNLRP3Neuroinflammation

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNLR ProteinsMahuang Lianqiao Chixiaodou DecoctionDrugs, Chinese Herbal

Autor:innen und Institutionen

  • School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China.
  • School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China. Electronic address: sunyan0205@163.com.
  • School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China. Electronic address: zhengfengjie@bucm.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Beijing University of Chinese Medicine

Zitieren

APA

Yuan, H., Tang, Y., Zhang, S., Yan, S., Li, A., Yu, Y., Sun, Y., & Zheng, F. (2024). NLRP3 neuroinflammatory intervention of Mahuang-Lianqiao-Chixiaodou decoction for mental disorders in atopic dermatitis mice. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2023.117263

Vancouver

Yuan H, Tang Y, Zhang S, Yan S, Li A, Yu Y, et al. NLRP3 neuroinflammatory intervention of Mahuang-Lianqiao-Chixiaodou decoction for mental disorders in atopic dermatitis mice. Journal of Ethnopharmacology. 2024. doi:10.1016/j.jep.2023.117263

BibTeX
@article{Yuan2024,
  author = {Yuan, Huimin and Tang, Yang and Zhang, Shujing and Yan, Shuxin and Li, Aorou and Yu, Yanru and Sun, Yan and Zheng, Fengjie},
  title = {NLRP3 neuroinflammatory intervention of Mahuang-Lianqiao-Chixiaodou decoction for mental disorders in atopic dermatitis mice},
  journal = {Journal of Ethnopharmacology},
  year = {2024},
  doi = {10.1016/j.jep.2023.117263}
}
Kostenlos starten →